Shareholders’ Equity (Deficit) (Details Narrative) - USD ($)				3 Months Ended		12 Months Ended
	Mar. 20, 2024	Nov. 02, 2023	Sep. 30, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of common stock				$ 3,195,201
Consulting expense			$ 30,000,000	$ 3,195,201
Common stock, shares authorized				299,000,000		299,000,000
Common stock par value				$ 0.0001		$ 0.0001
Share based payment award, options, grants in period, gross				68,800		4,743,356
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award, options, grants in period, gross				100
Preferred stock par value				$ 0.0001		$ 0.0001
Preferred stock voting rights				299
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award, options, grants in period, gross				100,000
Preferred stock par value				$ 0.0001		$ 0.0001
Preferred stock voting rights				10,000
Pre-funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of common stock, shares				1,477,892		1,575,000
Proceeds from issuance of warrants				$ 1,093,492		$ 2,110,342
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award, options, grants in period, gross						300,000
Restricted Stock [Member] | Operating Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Consulting expense					$ 631,822
Restricted Stock [Member] | Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Consulting expense				407,621
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Consulting expense				$ 30,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of common stock, shares	2,372,240	1,925,000		2,372,240
Proceeds from sale of common stock				$ 1,535,591
Consulting expense				$ 288
Number of shares issued				2,877,161
Proceeds from issuance of warrants	$ 2,629,083	$ 4,261,542
Common stock, shares authorized				299,000,000	299,000,000
Common Stock [Member] | Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Consulting expense				$ 304,188
Number of shares issued				214,537
Pre-funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued	1,477,892	1,575,000		1,477,892
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				7,700,264
ATM Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of common stock, shares				604,048
Proceeds from sale of common stock				$ 780,356
ATM Agreement [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of common stock, shares				504,921
Proceeds from sale of common stock				$ 566,118
Market Offering Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Consulting expense			$ 13,000,000	$ 13,000,000